实用药物与临床
實用藥物與臨床
실용약물여림상
PRACTICAL PHARMACY AND CLINICAL REMEDIES
2014年
11期
1406-1408,1409
,共4页
慢性阻塞性肺疾病急性加重期%降钙素原%Meta分析
慢性阻塞性肺疾病急性加重期%降鈣素原%Meta分析
만성조새성폐질병급성가중기%강개소원%Meta분석
Acute exacerbations of chronic obstructive pulmonary disease%Procalcitonin%Meta-analysis
目的:探讨在AECOPD抗感染治疗中监测PCT的价值。方法检索万方数据库、中国期刊全文数据库。纳入研究组为PCT指导组的临床随机对照试验。结果共纳入6个研究,Meta分析结果表明,以血清PCT含量0.25μg/L作为启用或停用抗菌药物的截断点可显著减少抗菌药物的使用;而且与常规治疗比较,疗效无显著差异。结论以血清PCT含量0.25μg/L作为AECOPD患者启用或停用抗菌药物的截断点可以在临床推广应用。
目的:探討在AECOPD抗感染治療中鑑測PCT的價值。方法檢索萬方數據庫、中國期刊全文數據庫。納入研究組為PCT指導組的臨床隨機對照試驗。結果共納入6箇研究,Meta分析結果錶明,以血清PCT含量0.25μg/L作為啟用或停用抗菌藥物的截斷點可顯著減少抗菌藥物的使用;而且與常規治療比較,療效無顯著差異。結論以血清PCT含量0.25μg/L作為AECOPD患者啟用或停用抗菌藥物的截斷點可以在臨床推廣應用。
목적:탐토재AECOPD항감염치료중감측PCT적개치。방법검색만방수거고、중국기간전문수거고。납입연구조위PCT지도조적림상수궤대조시험。결과공납입6개연구,Meta분석결과표명,이혈청PCT함량0.25μg/L작위계용혹정용항균약물적절단점가현저감소항균약물적사용;이차여상규치료비교,료효무현저차이。결론이혈청PCT함량0.25μg/L작위AECOPD환자계용혹정용항균약물적절단점가이재림상추엄응용。
Objective To investigate the effects of anti-infective therapy in acute exacerbations of chronic ob-structive pulmonary disease(AECOPD)monitored with procalcitonin(PCT). Methods China Academic Journals in Wanfang Database were searched. Studies with PCT as experimental parameter in randomized controlled trial were in-cluded in Meta-analysis. Results In six studies, antibiotics were significantly reduced after using serum PCT levels 0. 25 μg/L as truncation point. Efficacy had no significant difference in comparison with the conventional treatment. Conclusion Serum PCT levels 0. 25 μg/L in patients with AECOPD is a cut-off point for application of antibiotics.